Table 4

Characteristics of HRIs operated on for pancreatic masses

ID, age at surgerySexRiskImagingSurgeryPathologyMorbidityFollow-upFollow-up (months)
EUSMRI
25-4-25-204, 44 yearsFModHypoechoic mass (head)Negative (pancreas), 2 lesions (liver)Exploration, liver wedge resectionNo pancreatic tumour, FNH in wedge resectate of the liverNoneIncisional hernia93
25-2-28-204, 61 yearsFModHypoechoic massNegativeDP+SESerous oligocystic adenomaFistulaNo pathologies51
25-7-85-2, 61 yearsFHighCystic lesions (head and tail)Cystic lesions (head and tail)DP+SESerous oligocystic adenoma, lobular fibrosis with PanIN1NoneCystic lesion pancreatic head (prev known)60
25-7-41-109, 54 yearsMModHypoechoic mass (tail)Hypointense mass (tail)SPDPFocal fibrosis with PanIN1+PanIN2 lesionFistulaNo pathologies44
25-4-5-2, 42 yearsFModCystic lesion (corpus)Cystic lesion (corpus)SPDPSerous oligocystic adenomaNoneNo pathologies15
25-1-91-1, 54 yearsMHighHypoechoic mass (tail)NegativeDP+SELobular fibrosis with PanIN1+sqamous metaplasiaNoneNo pathologies12
25-5-67-24, 53 yearsFHighHypoechoic mass (tail)Hypointense mass (tail)SPDPLobular fibrosis with PanIN1+gastric type IPMNNoneNIDDM5
  • DP+SE, distal pancreatectomy+splenectomy; EUS, endoscopic ultrasound; fistula, postoperative pancreatic fistula (conservatively treated); FNH, focal nodular hyperplasia; HRI, high-risk individual; IPMN, intraductal pancreatic mucinous neoplasia; Mod, moderate; NIDDM, non-insulin-dependent diabetes mellitus; PAnIN, pancreatic intraepithelial neoplasia; prev known, previously known; SPDP, spleen-preserving distal pancreatectomy.